Users' rating    (0 vote)

Views 90

Favoured None

Italian version

Some studies calculate that the benefits gained by the use of statins in reducing heart attacks are well outweighed by the fact that these drugs are one of the major causes of the worldwide epidemic of congestive (or chronic) heart failure. The increase in this phenomenon is closely proportionate to the use of statins, drugs that receive powerful support from the pharmaceutical industry.

We must remember that statins represent the most-sold pharmacological group in the world with enormous sales rates and that the toxicological action of statins on the muscle is already known and has been the cause of numerous deaths and the recall of some statins from the market.

The scientific works are numerous: among others we cite the English Hargreaves IP study (Drug Saf. 2005; 28(8):659-76) and that of the American group from Albuquerque (Nawarskas JJ. Cardio Rev. 2oo5 Mar-Apr;13(2):76-9). These works document the deficiency of Ubiquinone (or Coenzyme Q10) in the tissue of those who are treated with statins.

We know how important Coenzyme Q10 is for sun-rash, for effective performance in sports activities and for aiding in the elimination of toxins, such as mercury.

Without a doubt, these are hard times for the pharmaceutical industry. This situation just might shed some light on the recent attack on natural and homeopathic medicine.

According to the scientific works by Golomb BA (Expert Opin Drug Saf. 2005 May;4(3):389-97) the persons who are most exposed to Coenzyme Q10 deficiency are the elderly.  Probably a great amount of the vascular damage that occurs in these people is written off to old age, while the effects are probably linked to pharmaceuticals.

All scientific studies exalt the positive effects of statins on acute cardiovascular illnesses (heart attacks) but no one considers the possibility that this type of therapy might cause cardiovascular damage of another sort.

The simple use of Coenzyme Q10 (from 15 to 60 mg per day, along with breakfast) would seem sufficient for controlling and preventing these aspects.

We would like to point out for everyone's benefit that, after the age of 65 (and maybe even before) those persons who have high cholesterol do not need to take drugs.

Eurosalus has already published numerous articles on this subject and several contain a clear discussion of the instruments necessary to understand whether a person actually has high cholesterol, evaluating the relationship between Total Cholesterol and HDL Cholesterol.

Doctor Attilio Speciani
Clinical Allergist and Immunologist

Italian version